首页|补肾化痰活血方对多囊卵巢综合征患者的促排卵作用及对抗米勒管激素、性激素水平的影响

补肾化痰活血方对多囊卵巢综合征患者的促排卵作用及对抗米勒管激素、性激素水平的影响

扫码查看
目的:探讨补肾化痰活血方对多囊卵巢综合征(PCOS)患者的促排卵作用及对抗米勒管激素(AMH)、性激素水平的影响。方法:选取2020 年 6 月至2022 年6 月河北省沧州中西医结合医院收治的PCOS患者124 例,按1∶1比例前瞻性随机分组。对照组 62 例患者给予氯米芬治疗,观察组 62 例患者给予氯米芬联合补肾化痰活血方治疗。对比两组患者的疗效、中医证候评分变化及不良反应发生情况,观察卵泡数、卵巢体积、子宫内膜厚度、排卵恢复情况及妊娠情况,检测血清雌二醇(E2)、睾酮(T)、黄体生成素(LH)、卵泡刺激素(FSH)和 AMH 水平。结果:观察组患者的综合疗效愈显率、总有效率分别为 85。48%(53/62)、100。00%(62/62),较对照组的 72。58%(45/62)、90。32%(56/62)明显升高,差异均有统计学意义(P<0。05)。与对照组比较,观察组患者治疗后的中医证候积分、卵泡数和卵巢体积均明显降低,而子宫内膜厚度明显增加,差异均有统计学意义(P<0。05)。与对照组比较,观察组患者治疗后血清E2 水平明显升高,而T、LH、LH/FSH和AMH水平明显降低,差异均有统计学意义(P<0。05)。观察组患者的排卵恢复率、随访 1 年妊娠率分别为 87。10%(54/62)、43。55%(27/62),较对照组的74。19%(46/62)、29。03%(18/62)明显升高,差异均有统计学意义(P<0。05)。两组患者不良反应发生率的差异无统计学意义(P>0。05),且均无严重不良反应。结论:补肾化痰活血方治疗PCOS患者,可改善临床症状,提高治疗效果,促进排卵并调节AMH和性激素水平,保护卵巢功能,增加妊娠机会。
Effects of Kidney-Tonifying,Phlegm-Eliminating and Blood-Activating Formula on Ovulation Induction and Anti-Müllerian Hormone,Sex Hormones Levels in Patients with Polycystic Ovary Syndrome
OBJECTIVE:To probe into the effects of kidney-tonifying,phlegm-eliminating and blood-activating formula on ovulation induction and anti-Müllerian hormone(AMH),sex hormones levels in patients with polycystic ovary syndrome(PCOS).METHODS:A total of 124 patients with PCOS admitted into Hebei Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine from Jun.2020 to Jun.2022 were selected and prospectively randomized at 1∶1 ratio.Totally 62 cases in the control group was given clomiphene,while 62 patients in observation group was treated with clomiphene combined with kidney-tonifying,phlegm-eliminating and blood-activating formula.Efficacy,changes in traditional Chinese medicine syndrome scores and incidences of adverse drug reactions were compared between two groups,the number of follicles,ovarian volume,endometrial thickness,recovery of ovulation and pregnancy were observed,the serum estradiol(E2),testosterone(T),luteinizing hormone(LH),follicle-stimulating hormone(FSH)and AMH were detected.RESULTS:The comprehensive curative effect rate and overall efficacy of the observation group were respectively 85.48%(53/62)and 100.00%(62/62),which were significantly higher than 72.58%(45/62)and 90.32%(56/62)of the control group,with statistically significant differences(P<0.05).Compared with the control group,the traditional Chinese medicine syndrome score,follicles number and ovarian volume of the observation group decreased significantly after treatment,while the endometrial thickness of the observation group increased significantly,with statistically significant differences(P<0.05).Compared with the control group,the serum E2 of the observation group increased significantly after treatment,while the levels of T,LH,LH/FSH and AMH in the observation group decreased significantly,with statistically significant differences(P<0.05).The recovery rate of ovulation and pregnancy rate of 1-year follow-up were respectively 87.10%(54/62)and 43.55%(27/62)in the observation group,significantly higher than 74.19%(46/62)and 29.03%(18/62)in the control group,with statistically significant differences(P<0.05).The difference in the incidences of adverse drug reactions between two groups was not statistically significant(P>0.05),and no severe adverse drug reactions occurred.CONCLUSIONS:Kidney-tonifying,phlegm-eliminating and blood-activating formula in the treatment of PCOS can improve patients'clinical symptoms,enhance therapeutic effect,promote ovulation,regulate AMH and sex hormones levels,protect ovarian function and increase the chance of pregnancy.

Kidney-tonifying,phlegm-eliminating and blood-activating formulaPolycystic ovary syndromeOvulationSex hormone

张云锋、王小洁、张新萍

展开 >

河北省沧州中西医结合医院中医专家门诊,河北 沧州 061001

邯郸市妇幼保健院中医妇科,河北 邯郸 056001

天津市第五中心医院中医科,天津 300450

补肾化痰活血方 多囊卵巢综合征 排卵 性激素

河北省中医药局科研项目

2022602

2024

中国医院用药评价与分析
中国医药生物技术协会,中国药房杂志社

中国医院用药评价与分析

CSTPCD
影响因子:1.142
ISSN:1672-2124
年,卷(期):2024.24(3)
  • 24